Description
Facts About JDRF
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is the largest charitable supporter of T1D research. The goal of JDRF is to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing the disease. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.6 billion to T1D research, including $116 million in FY2011. More than 80 percent of JDRF's expenditures directly support research and research-related education. Past JDRF research efforts have helped to significantly improve the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered.
A Transformative Vision
As the leader of the type 1 diabetes community, JDRF unifies global efforts to cure, treat, and prevent T1D. JDRF is committed, as we always have been, to delivering a cure for type 1 diabetes and its complications through the support of research. We are also focused on developing better treatments that transform the way people with T1D treat the disease today in order to help them live healthier lives now and in the future. Finally, JDRF focuses on prevention to keep future generations from getting T1D.
Guided by our vision of cure, treat, and prevent, JDRF-funded research encompasses T1D at every life-stage: stopping or slowing its progression in people who are newly diagnosed; reversing it in those who have lived with the disease for years; avoiding or reversing complications; and preventing the disease in people at risk and in future generations.
In addition to our research funding and leadership, JDRF's advocacy efforts help support a variety of issues that are critical to JDRF achieving its research objectives. Our focus includes increased government funding for T1D research and a regulatory environment that allows people with T1D to benefit from potential new therapies and devices as quickly and safely as possible. Finally, JDRF's outreach efforts provide practical support and resources for people with type 1 diabetes and their families every step of the way as they live with T1D.
Innovation and Collaboration
Research funded by JDRF has led to many landmark advances in type 1 diabetes science. We aggressively translate discoveries into treatments, drugs, and therapies that help people with T1D live healthier lives now, while we work toward a cure. Currently, JDRF is funding more than 53 human clinical trials, several of which are in the advanced stages of clinical testing needed before FDA approvals are required.
JDRF's influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia, and clinicians to ensure that JDRF and its partners are aligned and working toward a common goal of curing, treating, and preventing T1D.
Effective Operations
JDRF has always been dedicated to maintaining the highest levels of efficiency to ensure that our time, resources, and dollars can achieve the greatest possible impact on the lives of people with T1D. We have a solid track record of funding research efficiently and effectively. More than 80 percent of what JDRF spends goes directly to research and research-related education, which is among the highest percentages for charities nationwide.
Inspiring Results
JDRF was created-and is still led-by people with a personal connection to type 1 diabetes. Today, volunteers at JDRF's more than 100 locations worldwide remain the driving force behind our activities. That gives us an unrelenting passion and commitment to find a cure - and, in the near term, better treatments - for people with T1D.
All of JDRF's activities are driven by the needs of people with T1D. Whether it's providing funding for a late-stage clinical trial, lobbying the government for faster approval of new devices, or partnering with a company on research that might not otherwise receive funding, every decision JDRF makes is driven by our commitment to transforming the lives of people with T1D-and delivering a cure-as soon as possible.
Updated December 2011
